Outcomes after anti-thymocyte globulin vs Basiliximab induction before deceased donor kidney transplants

Transplant Immunology(2022)

引用 1|浏览0
暂无评分
摘要
•Anti-thymocyte induction has better outcomes than basiliximab after deceased donor renal transplant rATG patients have better patient and graft survival
更多
查看译文
关键词
Kidney transplantation,Graft survival,Rejection,Immunosuppression,Induction therapy
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要